Us Assisted Living Facility Neurorehabilitation Market: Market Size & Forecast 2026

The U.S. assisted living facility neurorehabilitation market represents a specialized and rapidly expanding segment of the broader post-acute care industry. In 2025, the market is valued at approximately $0.94 billion, with projections placing it on a strong upward trajectory at 13.65% annual growth. Neurorehabilitation services within ALFs span a range of evidence-based therapies designed to restore functional independence, improve quality of life, and reduce long-term healthcare costs associated with neurological conditions.

• •Market size reached roughly $0.94 billion in 2025, reflecting substantial investment in specialized ALF-based care
• •Annual growth rate of approximately 13.65% signals accelerating demand and provider capacity expansion
• •Services include physical therapy, occupational therapy, speech-language pathology, and cognitive remediation within ALF settings

The primary engine behind market expansion is the aging U.S. population, with the 85-and-over cohort, the group most susceptible to stroke and neurodegenerative diseases, expected to double between 2020 and 2050. Concurrently, assisted living facilities are increasingly positioning themselves as alternatives to skilled nursing facilities, and neurorehabilitation capabilities are a critical differentiator in that competitive positioning. Policy tailwinds, including expanded Medicare Advantage coverage of rehabilitation services and the ongoing shift toward value-based care models, are further incentivizing ALF operators to build or partner for in-house neurorehabilitation programs.

• •Over 7 million Americans live with a neurological condition requiring ongoing rehabilitation support, a figure that continues to climb
• •Assisted living facilities increasingly differentiate themselves by offering on-site or contracted neurorehabilitation programs rather than referring residents to external providers
• •Reimbursement landscape under Medicare, Medicaid, and Medicare Advantage increasingly supports bundled and value-based neurorehabilitation care models

Service type segmentation typically includes inpatient/habilitation-based therapy programs and outpatient community-based neurorehabilitation services, with the inpatient segment currently commanding the larger share due to the intensity of care required by most ALF neurorehabilitation patients. Geographically, the market is concentrated in the Northeast, Southeast, and Midwest, where ALF density and the elderly population are highest; states such as Florida, California, Texas, New York, and Pennsylvania collectively account for a significant proportion of market activity.

• •Northeast and Southeast U.S. lead in market activity due to high ALF density and large elderly populations
• •Florida and California represent two of the largest state markets, driven by retiree populations and extensive ALF networks
• •West Coast and Mountain states are emerging markets as ALF operators expand neurorehabilitation offerings in response to local demand

What are the recent trends and outlook?

Looking ahead, the market is expected to sustain its double-digit growth trajectory as the convergence of aging demographics, technology integration, and care model innovation reshapes how neurorehabilitation is delivered within assisted living environments. Tele-rehabilitation, AI-assisted therapy tools, and wearable sensor technology are beginning to play meaningful roles, allowing ALFs to extend the reach of licensed therapists and personalize treatment plans. The long-term outlook remains strongly favorable, with increasing evidence that ALF-based neurorehabilitation improves resident outcomes while reducing hospital readmissions, aligning well with broader healthcare system goals.

• •Tele-rehabilitation and digital therapeutic platforms are expanding access to neurorehabilitation services in rural and underserved ALF markets
• •Hospital-to-ALF care transition programs are incorporating structured neurorehabilitation pathways to reduce 30-day readmission rates
• •Federal and state policy initiatives aimed at supporting aging-in-place are expected to further incentivize ALF investment in neurorehabilitation infrastructure through 2030